4-Proposal-to-list-medical-devices-supplied-by-Device-Technologies-and-Med
Associate EMAC Instructor application form
NHMRC-grant-for-breakthrough-blood-research-12-Dec-2018
Two-new-leaders-for-ANZCA-and-FPM-11-May-2018
Interventional_Pain_Medicine
Periprocedural Diabetic Ketoacidosis (DKA) with SGLT2 Inhibitor Use
Alert update May 2023: Periprocedural diabetic ketoacidosis (DKA) with sodium-glucose co-transporter-2 inhibitor use in people with diabetes.
Tasmanian Health 22072002
ANZCA-response-to-ANZCOR-guideline-4-Airway-20210127
Tasmanian Health Service NWRH April 2021
ANZCA-response-to-TGA-repurposing-medicines-consultation-20210330